Ranbaxy Pharmaceuticals Inc., a unit of Sun Pharmaceutical Industries, has settled a patent litigation with Actavis over the generic version of Absorica, a drug used to treat acne.
Subscribe To Our Free Newsletter |
Ranbaxy Pharmaceuticals Inc., a unit of Sun Pharmaceutical Industries, has settled a patent litigation with Actavis over the generic version of Absorica, a drug used to treat acne.
Subscribe To Our Free Newsletter |
EvoLve theme by Theme4Press • Powered by WordPress & Rakesh Jhunjhunwala Latest Stock Market News
The Most Valuable Commodity Is Information!